Business Context and Reporting Period
AtriCure, Inc. (ATRC), a Delaware corporation, filed this Form 8-K on May 11, 2020, to report the entry into a material definitive agreement regarding a public offering of common stock.
Key Financial Metrics and Transaction Details
- Shares Offered: 3,977,273 shares of common stock.
- Public Offering Price: $44.00 per share.
- Underwriting Price: $41.36 per share.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to 596,590 additional shares.
- Expected Net Proceeds: Approximately $164.2 million (or $188.9 million if the over-allotment option is fully exercised), after deducting discounts, commissions, and estimated expenses.
- Use of Proceeds: Working capital, general corporate purposes, potential debt repayment, and market development activities.
- Expected Closing Date: On or about May 14, 2020.
Material Changes and Outlook
This filing represents a significant capital raise event rather than a periodic financial performance report. The transaction is expected to materially increase the company's liquidity position. The filing does not provide comparative revenue, profit, or margin data for the current period versus prior periods.
Risks and Contingencies
- Closing Conditions: The completion of the offering is subject to the satisfaction of customary closing conditions.
- Forward-Looking Statements: The filing contains forward-looking statements regarding the timing and size of the offering. Actual results may differ materially due to market conditions and other uncertainties.
- Assurance: There is no assurance that the offering will be completed on the anticipated terms or at all.
Investor Verification Checklist
- Verify the final closing date and whether the underwriters exercised the over-allotment option.
- Confirm the actual net proceeds received after final deduction of offering expenses.
- Review the full text of the Underwriting Agreement (Exhibit 1.1) for specific covenants and termination provisions.
- Monitor subsequent filings for updates on the specific allocation of proceeds, particularly regarding debt repayment.